NVDA · investment memo
own 10-K opex bridge: m_gross,T 70.0 - R&D 9.5 - SG&A 2.5 = 58.0. Constraint m_EBIT,T 58.0 <= m_gross,T 70.0 SATISFIED with 12.0pp headroom. BELOW trailing (TTM 64.02%, FY2026 60.38%) by design under State B, with a named causal bridge (rack-scale BOM pass-through, contractual HBM cost floor to CY2030, ASIC price ceiling, escalating internal-compute R&D, higher-cost ACIE distribution). NOTE: the pre-existing `terminal_margin` key on this record is the FRACTION 0.58; this field is the percent the contract asks for.
Four distinct questions, one field each. A price is not a thesis: the trigger below forces a re-underwrite and freezes further purchases — it is never an automatic sell.
A daily close below $167.21 triggers a mandatory re-underwrite and freezes further purchases. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.
Fundamental and falsifiable, never price-based. If one is satisfied the thesis is marked dead and the position is retained only by explicit decision.
Named cause: one of the three direct customers defers or re-phases its 2027 accelerator budget in favour of its own ASIC programme. The mechanism is fully specified by NVIDIA's own disclosures. The three customers are 21%, 17% and 16% of revenue. NVIDIA holds no RPO, no backlog, no take-or-pay and $160m of customer advances, so there is no contractual instrument to slow the transmission — the loss lands in the guided quarter. Simultaneously NVIDIA remains obliged on $119bn of supply commitments, $95bn of it inside nine months, which is what converted a demand shock into a $4.5bn inventory-and-